A USA Today article examines ICER’s role in the review the price and value of new drugs in the midst of rising drug costs, and explores the reactions of critics to ICER’s work. In a video interview accompanying the article, Dr. Steven Pearson, ICER’s President and Founder, provides added insight into ICER’s work.
